SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Nortran Pharmaceutical -NRT.V
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: David Culver who wrote (1003)11/18/1998 12:34:00 AM
From: SOROS   of 1185
 
Quality will win out. I have patience with NRT. Step by step they are climbing toward the goal. I don't really care if the stock goes up 50% each year or 200% in four. If they become the drug company I expect, we will be rewarded for patience. You may make more money trading for a year or two, but I will dollar cost average to accumulate. If NRT becomes a company with multiple drugs on the market, who do you think will hold more shares when it trades considerably higher -- the one accumulating or the trader?

I remain,

SOROS
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News